FDA

Latest News

February 25th 2025

FDA Approves Prolacta Bioscience’s Surgifort for Infants Recovering from Gastroschisis Surgery

By Don Tracy, Associate Editor

Surgifort is the first FDA-approved human milk-based fortifier specifically designed for term infants recovering from gastroschisis surgery.

February 25th 2025

FDA Grants Priority Review to Merck’s Keytruda for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

By Don Tracy, Associate Editor

February 18th 2025

Navigating Distrust: Pharma in the Age of Social Media

By Miranda Schmalfuhs

February 11th 2025

FDA Approves AbbVie’s Emblaveo for Complicated Intra-Abdominal Infections

By Don Tracy, Associate Editor

Trending on PharmExec

FDA Grants Ultomiris Accelerated Approval in the U.S. for Adults with Primary Immunoglobulin A Nephropathy

FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B

Pharmaceutical Executive Daily: FDA Grants Ultomiris Accelerated Approval in the U.S.

Roundup: Alcon Acquires Neurotech and Encelto, Ai Proteins Enters Research Collaboration and License Agreement with Astellas Pharma

Median Drug Launch Prices Hit $257,000 as Access Barriers Persist, ICER and West Health Report Finds